Cargando…

GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis

BACKGROUND: Chronic diseases are associated with an inflammatory response. We determined the association of two inflammatory markers, GlycA and high‐sensitivity C‐reactive protein (hsCRP), with overall and cause‐specific mortality in a cohort of men and women. METHODS: Cox regression analyses were u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruppen, E. G., Kunutsor, S. K., Kieneker, L. M., van der Vegt, B., Connelly, M. A., de Bock, G. H., Gansevoort, R. T., Bakker, S. J. L., Dullaart, R. P. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851697/ https://www.ncbi.nlm.nih.gov/pubmed/31260573 http://dx.doi.org/10.1111/joim.12953

Ejemplares similares

GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2015)

Urinary albumin excretion and cancer risk: the PREVEND cohort study
por: Luo, Li, et al.
Publicado: (2023)

GlycA: Evaluation of a New Biomarker of Acute Pancreatitis
por: Shah, Ishani, et al.
Publicado: (2023)

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
por: Connelly, Margery A., et al.
Publicado: (2017)

Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2018)

GlycA is not a useful biomarker of inflammation in sickle cell disease
por: Weisman, Julie K., et al.
Publicado: (2018)

Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
por: Kunutsor, Setor K., et al.
Publicado: (2019)

Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
por: Kunutsor, Setor K., et al.
Publicado: (2017)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022)

HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
por: Sokooti, Sara, et al.
Publicado: (2021)

Plasma Branched-Chain Amino Acids and Risk of Incident Type 2 Diabetes: Results from the PREVEND Prospective Cohort Study
por: Flores-Guerrero, Jose L., et al.
Publicado: (2018)

Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
por: Ormseth, Michelle J., et al.
Publicado: (2015)

Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes
por: Bartlett, David B., et al.
Publicado: (2017)

GlycA, a Biomarker of Low-Grade Inflammation, Is Increased in Male Night Shift Workers
por: Bizzarri, Daniele, et al.
Publicado: (2022)

Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates
por: Fung, Erik, et al.
Publicado: (2023)

Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
por: Riggs, Kayla A., et al.
Publicado: (2019)

Elevated serum alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality
por: Ritchie, Scott C., et al.
Publicado: (2019)

Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2017)

Cigarette smoking is associated with higher thyroid hormone and lower TSH levels: the PREVEND study
por: Gruppen, Eke G., et al.
Publicado: (2019)

Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
por: Assone, Tatiane, et al.
Publicado: (2022)

A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
por: Bartlett, David B., et al.
Publicado: (2016)

The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Jang, Sunyoung, et al.
Publicado: (2021)

GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()
por: Mehta, Nehal N., et al.
Publicado: (2020)

Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study
por: Minović, Isidor, et al.
Publicado: (2020)

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children
por: Connelly, Margery A., et al.
Publicado: (2016)

GlycA, a marker of protein glycosylation, is related to albuminuria and estimated glomerular filtration rate: the ELSA-Brasil study
por: Titan, Silvia M., et al.
Publicado: (2017)

Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife
por: Cohen-Manheim, Irit, et al.
Publicado: (2015)

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND
por: van der Leeuw, Joep, et al.
Publicado: (2020)

ProGlycProt: a repository of experimentally characterized prokaryotic glycoproteins
por: Bhat, Aadil H., et al.
Publicado: (2012)

Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort
por: Flores-Guerrero, Jose L., et al.
Publicado: (2020)

GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2020)

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
por: Dierckx, Tim, et al.
Publicado: (2020)

Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
por: Sokooti, Sara, et al.
Publicado: (2021)

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND
por: Suthahar, Navin, et al.
Publicado: (2022)

Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD
por: Dierckx, Tim, et al.
Publicado: (2019)

Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study
por: Sokooti, Sara, et al.
Publicado: (2021)

High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study
por: Garcia, Erwin, et al.
Publicado: (2019)

The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
por: Puig-Jové, Carlos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4pu3smfmcr9gauen17h4h3i49l